Goldman Sachs’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135K | Sell |
59,915
-50,431
| -46% | -$114K | ﹤0.01% | 4822 |
|
|
2025
Q1 | $295K | Sell |
110,346
-40,829
| -27% | -$109K | ﹤0.01% | 4520 |
|
|
2024
Q4 | $532K | Sell |
151,175
-83,690
| -36% | -$295K | ﹤0.01% | 4271 |
|
|
2024
Q3 | $1.11M | Buy |
234,865
+200,327
| +580% | +$950K | ﹤0.01% | 3694 |
|
|
2024
Q2 | $162K | Buy |
34,538
+12,320
| +55% | +$57.9K | ﹤0.01% | 4413 |
|
|
2024
Q1 | $101K | Buy |
+22,218
| New | +$101K | ﹤0.01% | 4461 |
|
|
2021
Q1 | – | Sell |
-10,816
| Closed | -$88K | – | 5229 |
|
|
2020
Q4 | $88K | Buy |
+10,816
| New | +$88K | ﹤0.01% | 4488 |
|
|
2020
Q1 | – | Sell |
-638
| Closed | -$7K | – | 4402 |
|
|
2019
Q4 | $7K | Buy |
+638
| New | +$7K | ﹤0.01% | 4263 |
|
|
2017
Q3 | – | Sell |
-8
| Closed | -$6K | – | 4257 |
|
|
2017
Q2 | $6K | Hold |
8
| – | – | ﹤0.01% | 4378 |
|
|
2017
Q1 | $8K | Hold |
8
| – | – | ﹤0.01% | 4375 |
|
|
2016
Q4 | $9K | Sell |
8
-1
| -11% | -$1.13K | ﹤0.01% | 4415 |
|
|
2016
Q3 | $10K | Sell |
9
-2
| -18% | -$2.22K | ﹤0.01% | 4497 |
|
|
2016
Q2 | $24K | Sell |
11
-2
| -15% | -$4.36K | ﹤0.01% | 4381 |
|
|
2016
Q1 | $20K | Sell |
13
-2
| -13% | -$3.08K | ﹤0.01% | 4372 |
|
|
2015
Q4 | $40K | Buy |
15
+2
| +15% | +$5.33K | ﹤0.01% | 4241 |
|
|
2015
Q3 | $63K | Sell |
13
-3
| -19% | -$14.5K | ﹤0.01% | 4284 |
|
|
2015
Q2 | $79K | Buy |
16
+2
| +14% | +$9.88K | ﹤0.01% | 4351 |
|
|
2015
Q1 | $66K | Sell |
14
-21
| -60% | -$99K | ﹤0.01% | 4240 |
|
|
2014
Q4 | $174K | Sell |
35
-19
| -35% | -$94.5K | ﹤0.01% | 4053 |
|
|
2014
Q3 | $319K | Buy |
54
+46
| +575% | +$272K | ﹤0.01% | 3618 |
|
|
2014
Q2 | $67K | Buy |
8
+5
| +167% | +$41.9K | ﹤0.01% | 4253 |
|
|
2014
Q1 | $76K | Buy |
+3
| New | +$76K | ﹤0.01% | 4181 |
|